Atlas Trials

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT03427827 · UNKNOWN

Trial details

NCT number
NCT03427827
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Neoplasms
Start date
2018-07-02
Primary completion
2024-02-06
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.